Evotec, Bristol Myers Squibb Protein Degradation Partnership Receives Second FDA Investigational New Drug Acceptance For CELMoD Candidate, Phase 1 Expected In 2027
Benzinga Newsdesk 21 hours ago
News
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
FDA clearance expands partnered molecular glue pipelineAchievement underscores productivity of the collaboration in molecular glue discovery and potential to address patient populations with high unmet need
- FDA clearance expands partnered molecular glue pipeline
- Achievement underscores productivity of the collaboration in molecular glue discovery and potential to address patient populations with high unmet need
